|
FAM45A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.29480001667781E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05530000293896E-08 |
| Normal-vs-Stage2 |
1.66409999999839E-05 |
| Normal-vs-Stage3 |
1.178580E-04 |
| Normal-vs-Stage4 |
3.380200E-03 |
| Stage1-vs-Stage2 |
8.528400E-01 |
| Stage1-vs-Stage3 |
3.707400E-01 |
| Stage1-vs-Stage4 |
7.004200E-01 |
| Stage2-vs-Stage3 |
5.620200E-01 |
| Stage2-vs-Stage4 |
7.300600E-01 |
| Stage3-vs-Stage4 |
9.338000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.28839996636077E-10 |
| Normal-vs-AfricanAmerican |
6.048600E-04 |
| Normal-vs-Asian |
2.851800E-01 |
| Caucasian-vs-AfricanAmerican |
2.831600E-01 |
| Caucasian-vs-Asian |
3.227400E-01 |
| AfricanAmerican-vs-Asian |
7.943600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.21231929945043E-12 |
| Normal-vs-Female |
1.179740E-02 |
| Male-vs-Female |
9.227000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.657700E-03 |
| Normal-vs-Extreme_Weight |
1.82598380860099E-12 |
| Normal-vs-Obese |
1.46880000051475E-07 |
| Normal-vs-Extreme_Obese |
4.11900000000243E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.602650E-01 |
| Normal_Weight-vs-Obese |
7.047800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.172600E-01 |
| Extreme_Weight-vs-Obese |
2.358200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.266400E-01 |
| Obese-vs-Extreme_Obese |
5.083200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.598000E-02 |
| Normal-vs-Age(41-60Yrs) |
7.53290000043982E-07 |
| Normal-vs-Age(61-80Yrs) |
4.175899626091E-10 |
| Normal-vs-Age(81-100Yrs) |
2.06319999995763E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.860000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.367900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.176200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.140300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.548800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.428800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.82580642113817E-12 |
| Normal-VS-Type2 PRCC |
4.823500E-04 |
| Normal-VS-KIRP CIMP |
3.106600E-01 |
| Normal-VS-Unclassified PRCC |
1.159120E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.738400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.240700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.853900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.192400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.412400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.000200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.99300001344238E-09 |
| Normal-vs-N1 |
3.621700E-02 |
| Normal-vs-N2 |
2.973400E-04 |
| N0-vs-N1 |
1.147750E-02 |
| N0-vs-N2 |
4.156000E-01 |
| N1-vs-N2 |
1.039750E-01 |
|
|
